Table 5.

Analysis for non-response to JAK inhibitors for 24 weeks in patients with RA.

	Univariate Model		Multivariate Model 1		Multivariate Model 2
Variable at Baseline	OR (95% CI)	p-Value	OR (95% CI)	p-Value	OR (95% CI)	p-Value
Swollen joint count	1.157 (1.009–1.328)	0.037	1.189 (1.027–1.378)	0.021	1.262 (1.038–1.535)	0.020
Rheumatoid factor	1.002 (1.000–1.005)	0.042	1.002 (1.000–1.004)	0.076
C-reactive protein	1.030 (1.003–1.057)	0.026	1.028 (1.000–1.057)	0.052
SII	1.000 (1.000–1.001)	0.225
NHL score	8.793 (0.378–204.795)	0.176
NLR	1.212 (0.912–1.811)	0.186
PLR	1.001 (0.993–1.008)	0.888

Data were described as odds ratios (ORs) and 95% confidence intervals (CIs). p-values were obtained by univariate and multivariate logistic regression analysis. Model 1, adjusted with age and gender; model 2, adjusted with age, gender, disease duration, and DAS28-ESR. Abbreviations: SII, systemic immune-inflammation index; NHL, neutrophil-to-hemoglobin and lymphocyte ratio; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio.